NDC 0006-0461

EMEND

Aprepitant

EMEND is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by Merck Sharp & Dohme Corp.. The primary component is Aprepitant.

• Product ID: 0006-0461_137e0347-9e23-4cc0-a44a-8c88d8983e17
• NDC: 0006-0461
• Product Type: Human Prescription Drug
• Proprietary Name: EMEND
• Generic Name: Aprepitant
• Dosage Form: Capsule
• Route of Administration: ORAL
• Marketing Start Date: 2003-03-26
• Marketing Category: NDA / NDA
• Application Number: NDA021549
• Labeler Name: Merck Sharp & Dohme Corp.
• Substance Name: APREPITANT
• Active Ingredient Strength: 80 mg/1
• Pharm Classes: Neurokinin 1 Antagonists [MoA],Substance P/Neurokinin-1 Receptor Antagonist [EPC],Cytochrome P450 3A4 Inhibitors [MoA],Cytochrome P450 2C9 Inducers [MoA],Cytochrome P450 3A4 Inducers [MoA]
• NDC Exclude Flag: N
• Listing Certified Through: 2021-12-31

Packaging

NDC 0006-0461-02

2 CAPSULE in 1 DOSE PACK (0006-0461-02)

• Marketing Start Date: 2003-03-26
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 0006-0461-02 [00006046102]

EMEND CAPSULE

• Marketing Category: NDA
• Application Number: NDA021549
• Product Type: HUMAN PRESCRIPTION DRUG
• Billing Unit: EA
• Marketing Start Date: 2003-03-26

NDC 0006-0461-06 [00006046106]

EMEND CAPSULE

• Marketing Category: NDA
• Application Number: NDA021549
• Product Type: HUMAN PRESCRIPTION DRUG
• Billing Unit: EA
• Marketing Start Date: 2003-03-26
• Marketing End Date: 2020-04-30

NDC 0006-0461-12 [00006046112]

EMEND CAPSULE

• Marketing Category: NDA
• Application Number: NDA021549
• Product Type: HUMAN PRESCRIPTION DRUG
• Marketing Start Date: 2003-03-26

NDC 0006-0461-30 [00006046130]

EMEND CAPSULE

• Marketing Category: NDA
• Application Number: NDA021549
• Product Type: HUMAN PRESCRIPTION DRUG
• Marketing Start Date: 2003-03-26
• Marketing End Date: 2010-07-14

NDC 0006-0461-01 [00006046101]

EMEND CAPSULE

• Marketing Category: NDA
• Application Number: NDA021549
• Product Type: HUMAN PRESCRIPTION DRUG
• Billing Unit: EA
• Marketing Start Date: 2003-03-26

Drug Details

Active Ingredients

Ingredient	Strength
APREPITANT	80 mg/1

OpenFDA Data

• SPL SET ID: 696f9e80-9cae-403b-de9e-078343ce4713
• Manufacturer:
  • Merck Sharp & Dohme Corp.
• UNII:
  • 1NF15YR6UY
• RxNorm Concept Unique ID - RxCUI:
  • 1729311
  • 403810
  • 403811
  • 644278
  • 754509
  • 754508
  • 644088
  • 404465
  • 404466
  • 1729308

Pharmacological Class

• Neurokinin 1 Antagonists [MoA]
• Substance P/Neurokinin-1 Receptor Antagonist [EPC]
• Cytochrome P450 3A4 Inhibitors [MoA]
• Cytochrome P450 2C9 Inducers [MoA]
• Cytochrome P450 3A4 Inducers [MoA]

NDC Crossover Matching brand name "EMEND" or generic name "Aprepitant"

NDC	Brand Name	Generic Name
0006-0461	EMEND	aprepitant
0006-0462	EMEND	aprepitant
0006-0464	EMEND	aprepitant
0006-3061	EMEND	FOSAPREPITANT DIMEGLUMINE
0006-3066	EMEND	aprepitant
0006-3862	EMEND	aprepitant
0006-3941	EMEND	EMEND
42254-160	EMEND	EMEND